Literature DB >> 15769645

Recent progress in the CYP51 research focusing on its unique evolutionary and functional characteristics as a diversozyme P450.

Yuri Aoyama1.   

Abstract

CYP51 (sterol 14-demethylase P450) is a family of P450 species having the same function in distinct kingdoms, which makes CYP51 a unique and important enzyme family for the discussion of evolution and diversification of P450. Although CYP51 was named to the P450 originally discovered in yeast and fungi, today, we know that members of CYP51 family exist ubiquitously in animals, plants, fishes, lower eukaryotes such as slime mold, and a part of bacteria. In this review, I describe following subjects: 1) CYP51 as a model family for understanding of diversification of P450, 2) the structure and function relationships of CYP51s.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15769645     DOI: 10.2741/1639

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  13 in total

1.  The A395T mutation in ERG11 gene confers fluconazole resistance in Candida tropicalis causing candidemia.

Authors:  Jingwen Tan; Jinqing Zhang; Wei Chen; Yi Sun; Zhe Wan; Ruoyu Li; Wei Liu
Journal:  Mycopathologia       Date:  2014-11-15       Impact factor: 2.574

Review 2.  Sterol 14alpha-demethylase cytochrome P450 (CYP51), a P450 in all biological kingdoms.

Authors:  Galina I Lepesheva; Michael R Waterman
Journal:  Biochim Biophys Acta       Date:  2006-08-02

3.  X-ray structure of 4,4'-dihydroxybenzophenone mimicking sterol substrate in the active site of sterol 14alpha-demethylase (CYP51).

Authors:  Ali Nasser Eddine; Jens P von Kries; Mikhail V Podust; Thulasi Warrier; Stefan H E Kaufmann; Larissa M Podust
Journal:  J Biol Chem       Date:  2008-03-26       Impact factor: 5.157

4.  A different function for a member of an ancient and highly conserved cytochrome P450 family: from essential sterols to plant defense.

Authors:  Xiaoquan Qi; Saleha Bakht; Bo Qin; Mike Leggett; Andrew Hemmings; Fred Mellon; John Eagles; Daniele Werck-Reichhart; Hubert Schaller; Agnes Lesot; Rachel Melton; Anne Osbourn
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-21       Impact factor: 11.205

5.  Identification of small-molecule scaffolds for p450 inhibitors.

Authors:  Jens P von Kries; Thulasi Warrier; Larissa M Podust
Journal:  Curr Protoc Microbiol       Date:  2010-02

6.  Small-molecule scaffolds for CYP51 inhibitors identified by high-throughput screening and defined by X-ray crystallography.

Authors:  Larissa M Podust; Jens P von Kries; Ali Nasser Eddine; Youngchang Kim; Liudmila V Yermalitskaya; Ronald Kuehne; Hugues Ouellet; Thulasi Warrier; Markus Alteköster; Jong-Seok Lee; Jörg Rademann; Hartmut Oschkinat; Stefan H E Kaufmann; Michael R Waterman
Journal:  Antimicrob Agents Chemother       Date:  2007-09-10       Impact factor: 5.191

7.  Interactions of antiparasitic sterols with sterol 14α-demethylase (CYP51) of human pathogens.

Authors:  Jasmine Warfield; William N Setzer; Ifedayo Victor Ogungbe
Journal:  Springerplus       Date:  2014-11-20

Review 8.  Drug strategies targeting CYP51 in neglected tropical diseases.

Authors:  Jun Yong Choi; Larissa M Podust; William R Roush
Journal:  Chem Rev       Date:  2014-10-22       Impact factor: 60.622

9.  Systematic and searchable classification of cytochrome P450 proteins encoded by fungal and oomycete genomes.

Authors:  Venkatesh Moktali; Jongsun Park; Natalie D Fedorova-Abrams; Bongsoo Park; Jaeyoung Choi; Yong-Hwan Lee; Seogchan Kang
Journal:  BMC Genomics       Date:  2012-10-04       Impact factor: 3.969

10.  Trypanosoma cruzi CYP51 inhibitor derived from a Mycobacterium tuberculosis screen hit.

Authors:  Chiung-Kuang Chen; Patricia S Doyle; Liudmila V Yermalitskaya; Zachary B Mackey; Kenny K H Ang; James H McKerrow; Larissa M Podust
Journal:  PLoS Negl Trop Dis       Date:  2009-02-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.